Overview
Translating Research Into Action for
Diabetes (TRIAD) is a national multi-center study that was
created to determine how managed care systems influence the processes
and outcomes of diabetes care. The study will describe and evaluate
the quality of care and life among people with diabetes through
the help from ten health plans and sixty-six provider groups.
For more information on the Federal Policy for the Protection
of Human Subjects, please click
here.
Mission
To improve the quality of care and quality of life for people with
diabetes.
To provide practical information on how to better implement effective
treatments for diabetic patients in the United States managed care
settings.
Collaborators
TRIAD includes six Translational Research Centers (TRCs). These centers collaborate with 10 health plans and 66 provider groups,
which serve approximately 180,000 patients with diabetes. The health
plans participating in TRIAD include staff model health maintenance
organizations (HMO), network/IPA model HMOs, point of service (POS)
plans, and preferred provider organizations (PPO). These plans include
for profit, not-for-profit, Medicare, and Medicaid providers. The
66 provider groups contracting with TRIADs partner health
plans were also recruited into the study.
Additional collaborators include the Veterans Health Administration's
(VHA) and the Social and Behavioral Research Institute
(SBRI).
Funding
TRIAD is supported by the Centers
for Disease Control and Prevention (CDC) in Atlanta, Georgia
and the National Institutes of Healths (NIH) National
Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
in Bethesda, Maryland.
|